ビタミンDの世界市場 2024-2028

ビタミンD市場は2023-2028年に6億6,532万米ドル、予測期間中のCAGRは7.86％で成長すると予測されます。

当レポートでは、ビタミンD市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、ビタミンDの重要性に対する意識の高まり、ビタミンD欠乏症の増加、老年人口の増加が牽引しています。

本調査では、eコマース市場の成長が今後数年間のビタミンD市場の成長を牽引する主要因の1つであるとしています。また、ヘルスケア支出の増加、ビーガンや植物ベースのライフスタイルの人気の高まりは、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム

第3章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模 2023
• 市場の見通し 2023-2028

第4章 市場規模実績

• ビタミンDの世界市場 2018-2022
• タイプセグメント分析 2018-2022
• 製品タイプセグメント分析 2018-2022
• 地域別セグメント分析 2018-2022
• 国別セグメント分析 2018-2022

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーション：タイプ別

• 市場セグメント
• 比較：タイプ別
• ビタミンD3：市場規模と予測 2023-2028
• ビタミンD2：市場規模と予測 2023-2028
• 市場機会：タイプ別

第7章 市場セグメンテーション：製品タイプ別

• 市場セグメント
• 比較：製品タイプ別
• OTC：市場規模と予測 2023-2028
• 処方箋：市場規模と予測 2023-2028
• 市場機会：製品タイプ別

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 2023-2028
• 欧州：市場規模と予測 2023-2028
• アジア：市場規模と予測 2023-2028
• 世界のその他の地域：市場規模と予測 2023-2028
• 米国：市場規模と予測 2023-2028
• カナダ：市場規模と予測 2023-2028
• ドイツ：市場規模と予測 2023-2028
• 中国：市場規模と予測 2023-2028
• 英国：市場規模と予測 2023-2028
• 市場機会：地域情勢別

第10章 促進要因、課題、および動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第11章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第12章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• BASF SE
• BioTech Pharmacal
• Dishman Carbogen Amcis Ltd.
• Fermenta Biotech Ltd.
• Glanbia plc
• GlaxoSmithKline Plc
• Kingdomway Nutrition Inc.
• Koninklijke DSM NV
• Nestle SA
• Pfizer Inc.
• Reckitt Benckiser Group Plc
• TAI ZHOU HISOU ND PHARMACEUTICAL CO.,LTD
• Torrent Pharmaceuticals Ltd.
• Zhejiang Garden Biochemical Hightech Co. Ltd.
• Zhejiang NHU Company Ltd.

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Type
• Exhibits6: Executive Summary - Chart on Market Segmentation by Product Type
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits18: Historic Market Size - Data Table on global vitamin d market 2018 - 2022 ($ million)
• Exhibits19: Historic Market Size - Type Segment 2018 - 2022 ($ million)
• Exhibits20: Historic Market Size - Product Type Segment 2018 - 2022 ($ million)
• Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2023 and 2028
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
• Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
• Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
• Exhibits29: Chart on Market condition - Five forces 2023 and 2028
• Exhibits30: Chart on Type - Market share 2023-2028 (%)
• Exhibits31: Data Table on Type - Market share 2023-2028 (%)
• Exhibits32: Chart on Comparison by Type
• Exhibits33: Data Table on Comparison by Type
• Exhibits34: Chart on Vitamin D3 - Market size and forecast 2023-2028 ($ million)
• Exhibits35: Data Table on Vitamin D3 - Market size and forecast 2023-2028 ($ million)
• Exhibits36: Chart on Vitamin D3 - Year-over-year growth 2023-2028 (%)
• Exhibits37: Data Table on Vitamin D3 - Year-over-year growth 2023-2028 (%)
• Exhibits38: Chart on Vitamin D2 - Market size and forecast 2023-2028 ($ million)
• Exhibits39: Data Table on Vitamin D2 - Market size and forecast 2023-2028 ($ million)
• Exhibits40: Chart on Vitamin D2 - Year-over-year growth 2023-2028 (%)
• Exhibits41: Data Table on Vitamin D2 - Year-over-year growth 2023-2028 (%)
• Exhibits42: Market opportunity by Type ($ million)
• Exhibits43: Data Table on Market opportunity by Type ($ million)
• Exhibits44: Chart on Product Type - Market share 2023-2028 (%)
• Exhibits45: Data Table on Product Type - Market share 2023-2028 (%)
• Exhibits46: Chart on Comparison by Product Type
• Exhibits47: Data Table on Comparison by Product Type
• Exhibits48: Chart on OTC - Market size and forecast 2023-2028 ($ million)
• Exhibits49: Data Table on OTC - Market size and forecast 2023-2028 ($ million)
• Exhibits50: Chart on OTC - Year-over-year growth 2023-2028 (%)
• Exhibits51: Data Table on OTC - Year-over-year growth 2023-2028 (%)
• Exhibits52: Chart on Rx - Market size and forecast 2023-2028 ($ million)
• Exhibits53: Data Table on Rx - Market size and forecast 2023-2028 ($ million)
• Exhibits54: Chart on Rx - Year-over-year growth 2023-2028 (%)
• Exhibits55: Data Table on Rx - Year-over-year growth 2023-2028 (%)
• Exhibits56: Market opportunity by Product Type ($ million)
• Exhibits57: Data Table on Market opportunity by Product Type ($ million)
• Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits59: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits61: Chart on Geographic comparison
• Exhibits62: Data Table on Geographic comparison
• Exhibits63: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits64: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits65: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits66: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits67: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits68: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits69: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits71: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits72: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits73: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits79: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibits80: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibits81: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits82: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits83: Chart on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibits84: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibits85: Chart on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits86: Data Table on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits89: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits91: Chart on China - Market size and forecast 2023-2028 ($ million)
• Exhibits92: Data Table on China - Market size and forecast 2023-2028 ($ million)
• Exhibits93: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibits94: Data Table on China - Year-over-year growth 2023-2028 (%)
• Exhibits95: Chart on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits97: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibits98: Data Table on UK - Year-over-year growth 2023-2028 (%)
• Exhibits99: Market opportunity By Geographical Landscape ($ million)
• Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ million)
• Exhibits101: Impact of drivers and challenges in 2023 and 2028
• Exhibits102: Overview on Criticality of inputs and Factors of differentiation
• Exhibits103: Overview on factors of disruption
• Exhibits104: Impact of key risks on business
• Exhibits105: Vendors covered
• Exhibits106: Matrix on vendor position and classification
• Exhibits107: BASF SE - Overview
• Exhibits108: BASF SE - Business segments
• Exhibits109: BASF SE - Key news
• Exhibits110: BASF SE - Key offerings
• Exhibits111: BASF SE - Segment focus
• Exhibits112: BioTech Pharmacal - Overview
• Exhibits113: BioTech Pharmacal - Product / Service
• Exhibits114: BioTech Pharmacal - Key offerings
• Exhibits115: Dishman Carbogen Amcis Ltd. - Overview
• Exhibits116: Dishman Carbogen Amcis Ltd. - Business segments
• Exhibits117: Dishman Carbogen Amcis Ltd. - Key offerings
• Exhibits118: Dishman Carbogen Amcis Ltd. - Segment focus
• Exhibits119: Fermenta Biotech Ltd. - Overview
• Exhibits120: Fermenta Biotech Ltd. - Business segments
• Exhibits121: Fermenta Biotech Ltd. - Key offerings
• Exhibits122: Fermenta Biotech Ltd. - Segment focus
• Exhibits123: Glanbia plc - Overview
• Exhibits124: Glanbia plc - Business segments
• Exhibits125: Glanbia plc - Key news
• Exhibits126: Glanbia plc - Key offerings
• Exhibits127: Glanbia plc - Segment focus
• Exhibits128: GlaxoSmithKline Plc - Overview
• Exhibits129: GlaxoSmithKline Plc - Business segments
• Exhibits130: GlaxoSmithKline Plc - Key news
• Exhibits131: GlaxoSmithKline Plc - Key offerings
• Exhibits132: GlaxoSmithKline Plc - Segment focus
• Exhibits133: Kingdomway Nutrition Inc. - Overview
• Exhibits134: Kingdomway Nutrition Inc. - Product / Service
• Exhibits135: Kingdomway Nutrition Inc. - Key offerings
• Exhibits136: Koninklijke DSM NV - Overview
• Exhibits137: Koninklijke DSM NV - Business segments
• Exhibits138: Koninklijke DSM NV - Key news
• Exhibits139: Koninklijke DSM NV - Key offerings
• Exhibits140: Koninklijke DSM NV - Segment focus
• Exhibits141: Nestle SA - Overview
• Exhibits142: Nestle SA - Business segments
• Exhibits143: Nestle SA - Key news
• Exhibits144: Nestle SA - Key offerings
• Exhibits145: Nestle SA - Segment focus
• Exhibits146: Pfizer Inc. - Overview
• Exhibits147: Pfizer Inc. - Product / Service
• Exhibits148: Pfizer Inc. - Key news
• Exhibits149: Pfizer Inc. - Key offerings
• Exhibits150: Reckitt Benckiser Group Plc - Overview
• Exhibits151: Reckitt Benckiser Group Plc - Business segments
• Exhibits152: Reckitt Benckiser Group Plc - Key offerings
• Exhibits153: Reckitt Benckiser Group Plc - Segment focus
• Exhibits154: TAI ZHOU HISOU ND PHARMACEUTICAL CO.,LTD - Overview
• Exhibits155: TAI ZHOU HISOU ND PHARMACEUTICAL CO.,LTD - Key offerings
• Exhibits156: Torrent Pharmaceuticals Ltd. - Overview
• Exhibits157: Torrent Pharmaceuticals Ltd. - Business segments
• Exhibits158: Torrent Pharmaceuticals Ltd. - Key offerings
• Exhibits159: Torrent Pharmaceuticals Ltd. - Segment focus
• Exhibits160: Zhejiang Garden Biochemical Hightech Co. Ltd. - Overview
• Exhibits161: Zhejiang Garden Biochemical Hightech Co. Ltd. - Business segments
• Exhibits162: Zhejiang Garden Biochemical Hightech Co. Ltd. - Key offerings
• Exhibits163: Zhejiang Garden Biochemical Hightech Co. Ltd. - Segment focus
• Exhibits164: Zhejiang NHU Company Ltd. - Overview
• Exhibits165: Zhejiang NHU Company Ltd. - Product / Service
• Exhibits166: Zhejiang NHU Company Ltd. - Key offerings
• Exhibits167: Inclusions checklist
• Exhibits168: Exclusions checklist
• Exhibits169: Currency conversion rates for US$
• Exhibits170: Research methodology
• Exhibits171: Validation techniques employed for market sizing
• Exhibits172: Information sources
• Exhibits173: List of abbreviations

The vitamin D market is forecasted to grow by USD 665.32 mn during 2023-2028, accelerating at a CAGR of 7.86% during the forecast period. The report on the vitamin d market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing awareness about importance of vitamin D, increase in number of vitamin d deficiency disorders, and growing geriatric population.

Technavio's vitamin D market is segmented as below:

By Type

• Vitamin D3
• Vitamin D2

By Product Type

• OTC
• Rx

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the growing e-commerce market as one of the prime reasons driving the vitamin D market growth during the next few years. Also, increasing healthcare expenditure and increasing popularity of vegan and plant-based lifestyles will lead to sizable demand in the market.

The report on the vitamin D market covers the following areas:

• Vitamin D market sizing
• Vitamin D market forecast
• Vitamin D market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading vitamin D market vendors that include Abbott Laboratories, Archer Daniels Midland Co., BASF SE, BioTech Pharmacal, Cadila Pharmaceuticals Ltd., Church and Dwight Co. Inc., Dishman Carbogen Amcis Ltd., Fermenta Biotech Ltd., Glanbia plc, GlaxoSmithKline Plc, INLIFE Pharma Pvt. Ltd., Kingdomway Nutrition Inc., Koninklijke DSM NV, Nestle SA, Pfizer Inc., Reckitt Benckiser Group Plc, Sun Pharmaceutical Industries Ltd., TAI ZHOU HISOU ND PHARMACEUTICAL CO.,LTD, Xiamen Jindawei Group Co. Ltd., Zhejiang Garden Biochemical Hightech Co. Ltd., Zhejiang NHU Company Ltd., Divis Nutraceuticals, and Torrent Pharmaceuticals Ltd.. Also, the vitamin d market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Product Type
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
• Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global vitamin D market 2018 - 2022
• Exhibit 18: Historic Market Size - Data Table on global vitamin d market 2018 - 2022 ($ million)
• 4.2 Type Segment Analysis 2018 - 2022
• Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ million)
• 4.3 Product Type Segment Analysis 2018 - 2022
• Exhibit 20: Historic Market Size - Product Type Segment 2018 - 2022 ($ million)
• 4.4 Geography Segment Analysis 2018 - 2022
• Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 4.5 Country Segment Analysis 2018 - 2022
• Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type

• 6.1 Market segments
• Exhibit 30: Chart on Type - Market share 2023-2028 (%)
• Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
• 6.2 Comparison by Type
• Exhibit 32: Chart on Comparison by Type
• Exhibit 33: Data Table on Comparison by Type
• 6.3 Vitamin D3 - Market size and forecast 2023-2028
• Exhibit 34: Chart on Vitamin D3 - Market size and forecast 2023-2028 ($ million)
• Exhibit 35: Data Table on Vitamin D3 - Market size and forecast 2023-2028 ($ million)
• Exhibit 36: Chart on Vitamin D3 - Year-over-year growth 2023-2028 (%)
• Exhibit 37: Data Table on Vitamin D3 - Year-over-year growth 2023-2028 (%)
• 6.4 Vitamin D2 - Market size and forecast 2023-2028
• Exhibit 38: Chart on Vitamin D2 - Market size and forecast 2023-2028 ($ million)
• Exhibit 39: Data Table on Vitamin D2 - Market size and forecast 2023-2028 ($ million)
• Exhibit 40: Chart on Vitamin D2 - Year-over-year growth 2023-2028 (%)
• Exhibit 41: Data Table on Vitamin D2 - Year-over-year growth 2023-2028 (%)
• 6.5 Market opportunity by Type
• Exhibit 42: Market opportunity by Type ($ million)
• Exhibit 43: Data Table on Market opportunity by Type ($ million)

7 Market Segmentation by Product Type

• 7.1 Market segments
• Exhibit 44: Chart on Product Type - Market share 2023-2028 (%)
• Exhibit 45: Data Table on Product Type - Market share 2023-2028 (%)
• 7.2 Comparison by Product Type
• Exhibit 46: Chart on Comparison by Product Type
• Exhibit 47: Data Table on Comparison by Product Type
• 7.3 OTC - Market size and forecast 2023-2028
• Exhibit 48: Chart on OTC - Market size and forecast 2023-2028 ($ million)
• Exhibit 49: Data Table on OTC - Market size and forecast 2023-2028 ($ million)
• Exhibit 50: Chart on OTC - Year-over-year growth 2023-2028 (%)
• Exhibit 51: Data Table on OTC - Year-over-year growth 2023-2028 (%)
• 7.4 Rx - Market size and forecast 2023-2028
• Exhibit 52: Chart on Rx - Market size and forecast 2023-2028 ($ million)
• Exhibit 53: Data Table on Rx - Market size and forecast 2023-2028 ($ million)
• Exhibit 54: Chart on Rx - Year-over-year growth 2023-2028 (%)
• Exhibit 55: Data Table on Rx - Year-over-year growth 2023-2028 (%)
• 7.5 Market opportunity by Product Type
• Exhibit 56: Market opportunity by Product Type ($ million)
• Exhibit 57: Data Table on Market opportunity by Product Type ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 59: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibit 60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
• Exhibit 61: Chart on Geographic comparison
• Exhibit 62: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• Exhibit 63: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibit 64: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibit 65: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibit 66: Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
• Exhibit 67: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibit 68: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibit 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibit 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
• Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
• Exhibit 79: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibit 80: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibit 81: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibit 82: Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 Canada - Market size and forecast 2023-2028
• Exhibit 83: Chart on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibit 84: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibit 85: Chart on Canada - Year-over-year growth 2023-2028 (%)
• Exhibit 86: Data Table on Canada - Year-over-year growth 2023-2028 (%)
• 9.9 Germany - Market size and forecast 2023-2028
• Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.10 China - Market size and forecast 2023-2028
• Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ million)
• Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ million)
• Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.11 UK - Market size and forecast 2023-2028
• Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ million)
• Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
• Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 99: Market opportunity By Geographical Landscape ($ million)
• Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 101: Impact of drivers and challenges in 2023 and 2028
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 103: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 104: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 105: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 106: Matrix on vendor position and classification
• 12.3 BASF SE
• Exhibit 107: BASF SE - Overview
• Exhibit 108: BASF SE - Business segments
• Exhibit 109: BASF SE - Key news
• Exhibit 110: BASF SE - Key offerings
• Exhibit 111: BASF SE - Segment focus
• 12.4 BioTech Pharmacal
• Exhibit 112: BioTech Pharmacal - Overview
• Exhibit 113: BioTech Pharmacal - Product / Service
• Exhibit 114: BioTech Pharmacal - Key offerings
• 12.5 Dishman Carbogen Amcis Ltd.
• Exhibit 115: Dishman Carbogen Amcis Ltd. - Overview
• Exhibit 116: Dishman Carbogen Amcis Ltd. - Business segments
• Exhibit 117: Dishman Carbogen Amcis Ltd. - Key offerings
• Exhibit 118: Dishman Carbogen Amcis Ltd. - Segment focus
• 12.6 Fermenta Biotech Ltd.
• Exhibit 119: Fermenta Biotech Ltd. - Overview
• Exhibit 120: Fermenta Biotech Ltd. - Business segments
• Exhibit 121: Fermenta Biotech Ltd. - Key offerings
• Exhibit 122: Fermenta Biotech Ltd. - Segment focus
• 12.7 Glanbia plc
• Exhibit 123: Glanbia plc - Overview
• Exhibit 124: Glanbia plc - Business segments
• Exhibit 125: Glanbia plc - Key news
• Exhibit 126: Glanbia plc - Key offerings
• Exhibit 127: Glanbia plc - Segment focus
• 12.8 GlaxoSmithKline Plc
• Exhibit 128: GlaxoSmithKline Plc - Overview
• Exhibit 129: GlaxoSmithKline Plc - Business segments
• Exhibit 130: GlaxoSmithKline Plc - Key news
• Exhibit 131: GlaxoSmithKline Plc - Key offerings
• Exhibit 132: GlaxoSmithKline Plc - Segment focus
• 12.9 Kingdomway Nutrition Inc.
• Exhibit 133: Kingdomway Nutrition Inc. - Overview
• Exhibit 134: Kingdomway Nutrition Inc. - Product / Service
• Exhibit 135: Kingdomway Nutrition Inc. - Key offerings
• 12.10 Koninklijke DSM NV
• Exhibit 136: Koninklijke DSM NV - Overview
• Exhibit 137: Koninklijke DSM NV - Business segments
• Exhibit 138: Koninklijke DSM NV - Key news
• Exhibit 139: Koninklijke DSM NV - Key offerings
• Exhibit 140: Koninklijke DSM NV - Segment focus
• 12.11 Nestle SA
• Exhibit 141: Nestle SA - Overview
• Exhibit 142: Nestle SA - Business segments
• Exhibit 143: Nestle SA - Key news
• Exhibit 144: Nestle SA - Key offerings
• Exhibit 145: Nestle SA - Segment focus
• 12.12 Pfizer Inc.
• Exhibit 146: Pfizer Inc. - Overview
• Exhibit 147: Pfizer Inc. - Product / Service
• Exhibit 148: Pfizer Inc. - Key news
• Exhibit 149: Pfizer Inc. - Key offerings
• 12.13 Reckitt Benckiser Group Plc
• Exhibit 150: Reckitt Benckiser Group Plc - Overview
• Exhibit 151: Reckitt Benckiser Group Plc - Business segments
• Exhibit 152: Reckitt Benckiser Group Plc - Key offerings
• Exhibit 153: Reckitt Benckiser Group Plc - Segment focus
• 12.14 TAI ZHOU HISOU ND PHARMACEUTICAL CO.,LTD
• Exhibit 154: TAI ZHOU HISOU ND PHARMACEUTICAL CO.,LTD - Overview
• Exhibit 155: TAI ZHOU HISOU ND PHARMACEUTICAL CO.,LTD - Key offerings
• 12.15 Torrent Pharmaceuticals Ltd.
• Exhibit 156: Torrent Pharmaceuticals Ltd. - Overview
• Exhibit 157: Torrent Pharmaceuticals Ltd. - Business segments
• Exhibit 158: Torrent Pharmaceuticals Ltd. - Key offerings
• Exhibit 159: Torrent Pharmaceuticals Ltd. - Segment focus
• 12.16 Zhejiang Garden Biochemical Hightech Co. Ltd.
• Exhibit 160: Zhejiang Garden Biochemical Hightech Co. Ltd. - Overview
• Exhibit 161: Zhejiang Garden Biochemical Hightech Co. Ltd. - Business segments
• Exhibit 162: Zhejiang Garden Biochemical Hightech Co. Ltd. - Key offerings
• Exhibit 163: Zhejiang Garden Biochemical Hightech Co. Ltd. - Segment focus
• 12.17 Zhejiang NHU Company Ltd.
• Exhibit 164: Zhejiang NHU Company Ltd. - Overview
• Exhibit 165: Zhejiang NHU Company Ltd. - Product / Service
• Exhibit 166: Zhejiang NHU Company Ltd. - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 167: Inclusions checklist
• Exhibit 168: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 169: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 170: Research methodology
• Exhibit 171: Validation techniques employed for market sizing
• Exhibit 172: Information sources
• 13.5 List of abbreviations
• Exhibit 173: List of abbreviations